$Tevogen Bio Holdings (TVGN.US)$ LATE NEWS FRIDAY AM (6PM) T...
LATE NEWS FRIDAY AM (6PM)
Tevogen Bio Announces up to $50 Million in Financing to Further Advance Operational Objectives
Tevogen Bio Holdings Inc. has secured up to $50 million in financing to advance its ExacTcell platform and further clinical trials. The financing supports ongoing research and development efforts, including expanding clinical trials for TVGN 489 in oncology, neurology, and virology. The capital will also aid in starting new trials for virally induced cancers and multiple sclerosis. Dr. Ryan Saadi, Tevogen Bio's CEO, expressed gratitude for the support of existing shareholders, emphasizing the company's commitment to providing affordable T cell therapies for a wide range of patients.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
629Followers
74Following
4033Visitors
Follow